Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies.

Endosialin (CD248, TEM-1) is expressed in pericytes, tumor vasculature, tumor fibroblasts, and some tumor cells, including sarcomas, with limited normal tissue expression, and appears to play a key role in tumor-stromal interactions, including angiogenesis. Monoclonal antibodies targeting endosialin...

Descripción completa

Detalles Bibliográficos
Publicado en:Sarcoma pp. 1 - 14
Autores principales: O’Shannessy, Daniel J., Dai, Hongyue, Mitchell, Melissa, Huntsman, Shane, Brantley, Stephen, Fenstermacher, David, Reed, Damon R.
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell 1/27/2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=113627956&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 113627956
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1357714X
        57R
      jtl: Sarcoma
      issn: 1357714X
      maglogo: Y
    pubinfo:
      dt: 1/27/2016
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        113627956
        113627956
        113627956
        10.1155/2016/5213628
        113627956
      ppf: 1
      ppct: 13
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies.
      aug:
        au:
          O’Shannessy, Daniel J.
          Dai, Hongyue
          Mitchell, Melissa
          Huntsman, Shane
          Brantley, Stephen
          Fenstermacher, David
          Reed, Damon R.
        affil: Translational Medicine and Diagnostics, Morphotek, Inc., Exton, PA 19341, USA
      sug:
        subj:
          Bioinformatics
          Gene Expression
          Leiomyosarcoma
          Sarcoma
          Neoplasms
          Carbonic Anhydrases
          Human
          Immunohistochemistry
          Antibodies, Monoclonal
      ab: Endosialin (CD248, TEM-1) is expressed in pericytes, tumor vasculature, tumor fibroblasts, and some tumor cells, including sarcomas, with limited normal tissue expression, and appears to play a key role in tumor-stromal interactions, including angiogenesis. Monoclonal antibodies targeting endosialin have entered clinical trials, including soft tissue sarcomas. We evaluated a cohort of 94 soft tissue sarcoma samples to assess the correlation between gene expression and protein expression by immunohistochemistry for endosialin and PDGFR-β, a reported interacting protein, across available diagnoses. Correlations between the expression of endosialin and 13 other genes of interest were also examined. Within cohorts of soft tissue diagnoses assembled by tissue type (liposarcoma, leiomyosarcoma, undifferentiated sarcoma, and other), endosialin expression was significantly correlated with a better outcome. Endosialin expression was highest in liposarcomas and lowest in leiomyosarcomas. A robust correlation between protein and gene expression data for both endosialin and PDGFR-β was observed. Endosialin expression positively correlated with PDGFR-β and heparin sulphate proteoglycan 2 and negatively correlated with carbonic anhydrase IX. Endosialin likely interacts with a network of extracellular and hypoxia activated proteins in sarcomas and other tumor types. Since expression does vary across histologic groups, endosialin may represent a selective target in soft tissue sarcomas.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N